Eisuke Tomiyama

1.1k total citations
33 papers, 502 citations indexed

About

Eisuke Tomiyama is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Eisuke Tomiyama has authored 33 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 14 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Eisuke Tomiyama's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (10 papers) and Renal cell carcinoma treatment (8 papers). Eisuke Tomiyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (10 papers) and Renal cell carcinoma treatment (8 papers). Eisuke Tomiyama collaborates with scholars based in Japan, United States and Germany. Eisuke Tomiyama's co-authors include Norio Nonomura, Kazutoshi Fujita, Koji Hatano, Atsunari Kawashima, Yujiro Hayashi, Taigo Kato, Hirotsugu Uemura, Motohide Uemura, Makoto Matsushita and Takeshi Ujike and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Eisuke Tomiyama

33 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eisuke Tomiyama Japan	13	248	178	151	136	135	33	502
Manuel Caitano Maia United States	10	267 1.1×	90 0.5×	284 1.9×	234 1.7×	154 1.1×	26	534
Liang Zhu China	15	359 1.4×	65 0.4×	193 1.3×	129 0.9×	175 1.3×	35	602
Tahir Qayyum United Kingdom	11	137 0.6×	55 0.3×	116 0.8×	144 1.1×	93 0.7×	20	386
Shinya Ohara Japan	12	115 0.5×	135 0.8×	152 1.0×	159 1.2×	43 0.3×	29	376
Clemens Thoma United States	8	170 0.7×	55 0.3×	94 0.6×	120 0.9×	52 0.4×	106	361
Zongming Lin China	11	158 0.6×	88 0.5×	128 0.8×	140 1.0×	50 0.4×	18	374
Shuishen Zhang China	13	302 1.2×	148 0.8×	141 0.9×	111 0.8×	150 1.1×	32	518
Chenfei Chi China	14	168 0.7×	41 0.2×	287 1.9×	177 1.3×	168 1.2×	26	489
Guo Long China	13	213 0.9×	60 0.3×	152 1.0×	170 1.3×	165 1.2×	26	492
J. Varthalitis Greece	9	102 0.4×	111 0.6×	114 0.8×	280 2.1×	97 0.7×	17	421

Countries citing papers authored by Eisuke Tomiyama

Since Specialization

Citations

This map shows the geographic impact of Eisuke Tomiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eisuke Tomiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eisuke Tomiyama more than expected).

Fields of papers citing papers by Eisuke Tomiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eisuke Tomiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eisuke Tomiyama. The network helps show where Eisuke Tomiyama may publish in the future.

Co-authorship network of co-authors of Eisuke Tomiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Eisuke Tomiyama. A scholar is included among the top collaborators of Eisuke Tomiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eisuke Tomiyama. Eisuke Tomiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomiyama, Eisuke, Kazutoshi Fujita, Mamoru Hashimoto, Hirotsugu Uemura, & Norio Nonomura. (2023). Urinary markers for bladder cancer diagnosis: A review of current status and future challenges. International Journal of Urology. 31(3). 208–219. 21 indexed citations

Kato, Taigo, Eisuke Tomiyama, Yu Ishizuya, et al.. (2023). Prognostic significance of serum fucosylated pro-haptoglobin in advanced renal cell carcinoma patients treated with immune checkpoint inhibitors. Scientific Reports. 13(1). 17239–17239. 1 indexed citations

Uemura, Toshihiro, Atsunari Kawashima, Kentaro Jingushi, et al.. (2023). Bacteria-derived DNA in serum extracellular vesicles are biomarkers for renal cell carcinoma. Heliyon. 9(9). e19800–e19800. 9 indexed citations

Hashimoto, Mamoru, Kazutoshi Fujita, Eisuke Tomiyama, et al.. (2022). Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma. Anticancer Research. 43(1). 167–174. 9 indexed citations

Jingushi, Kentaro, Atsunari Kawashima, Takuro Saito, et al.. (2022). Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients. Cancer Immunology Immunotherapy. 71(12). 2999–3011. 10 indexed citations

Hatano, Koji, Akinaru Yamamoto, Toshihiro Uemura, et al.. (2022). The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer. International Journal of Clinical Oncology. 28(3). 427–435. 2 indexed citations

Hayashi, Yujiro, Kazutoshi Fujita, Kazuko Sakai, et al.. (2022). Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer. Scientific Reports. 12(1). 16642–16642. 2 indexed citations

Yamamoto, Yoshiyuki, Atsunari Kawashima, Toshitaka Morishima, et al.. (2022). Comparative Effectiveness of Radiation Versus Radical Cystectomy for Localized Muscle-Invasive Bladder Cancer. Advances in Radiation Oncology. 8(3). 101157–101157. 3 indexed citations

Yamamoto, Akinaru, Atsunari Kawashima, Toshihiro Uemura, et al.. (2022). Biological distinction between grades 2 and 3 with respect to intravesical recurrence in T1 high-grade bladder tumors: a retrospective study. BMC Urology. 22(1). 59–59. 1 indexed citations

10.

Hatano, Koji, Tohru Yoneyama, Shingo Hatakeyama, et al.. (2021). Simultaneous analysis of serum α2,3-linked sialylation and core-type fucosylation of prostate-specific antigen for the detection of high-grade prostate cancer. British Journal of Cancer. 126(5). 764–770. 17 indexed citations

11.

Matsuzaki, Kyosuke, Kazutoshi Fujita, Eisuke Tomiyama, et al.. (2021). MiR-30b-3p and miR-126-3p of urinary extracellular vesicles could be new biomarkers for prostate cancer. Translational Andrology and Urology. 10(4). 1918–1927. 34 indexed citations

12.

Fujita, Kazutoshi, Koji Hatano, Eisuke Tomiyama, et al.. (2021). Serum core‐type fucosylated prostate‐specific antigen index for the detection of high‐risk prostate cancer. International Journal of Cancer. 148(12). 3111–3118. 18 indexed citations

13.

Kato, Taigo, Kazuma Kiyotani, Eisuke Tomiyama, et al.. (2021). Peripheral T cell receptor repertoire features predict durable responses to anti-PD-1 inhibitor monotherapy in advanced renal cell carcinoma. OncoImmunology. 10(1). 1862948–1862948. 29 indexed citations

14.

Tomiyama, Eisuke, Kazutoshi Fujita, Mamoru Hashimoto, et al.. (2021). Programmed cell death‐ligand 1 expression in different molecular subtypes of upper tract urothelial carcinoma. International Journal of Urology. 29(1). 89–90. 1 indexed citations

15.

Hayashi, Yujiro, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.. (2020). Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer. Frontiers in Oncology. 10. 755–755. 32 indexed citations

16.

Kato, Taigo, Eisuke Tomiyama, Yoko Koh, et al.. (2020). A Potential Mechanism of Anticancer Immune Response Coincident With Immune-related Adverse Events in Patients With Renal Cell Carcinoma. Anticancer Research. 40(9). 4875–4883. 9 indexed citations

17.

Hayashi, Yujiro, Kazutoshi Fujita, Satoshi Nojima, et al.. (2020). TERT C228T mutation in non‐malignant bladder urothelium is associated with intravesical recurrence for patients with non‐muscle invasive bladder cancer. Molecular Oncology. 14(10). 2375–2383. 24 indexed citations

18.

Ishizuya, Yu, Motohide Uemura, Ryohei Narumi, et al.. (2020). The role of actinin-4 (ACTN4) in exosomes as a potential novel therapeutic target in castration-resistant prostate cancer. Biochemical and Biophysical Research Communications. 523(3). 588–594. 34 indexed citations

19.

Wang, Cong, Motohide Uemura, Eisuke Tomiyama, et al.. (2020). MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma. Cancer Science. 111(4). 1146–1155. 22 indexed citations

20.

Kawashima, Atsunari, Motohide Uemura, Taigo Kato, et al.. (2018). Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma. International Journal of Clinical Oncology. 24(1). 78–86. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact